Throughout history, infectious diseases have vastly impacted human civilization. Around fifty years ago, many people believed that the age-old battle of humans against infectious disease was virtually over and that humankind were the winners [1,2]. Unfortunately, several new diseases emerged during the past decades (such as AIDS, West Nile fever, and Legionnaires’ disease) [2,3]. In addition, certain traditional diseases resurged with full effects (such as malaria, Lyme disease, and tuberculosis) [3]. Globally, infectious diseases remain the leading cause of death, therefore it is clear that humans are yet to be declared the winners in this battle against infectious diseases.
Infectious diseases have continuously affected human health and there has been a relentless appearance of various infectious disease outbreaks reported, including the plague that scourged Europe during the Middle Ages [4], yellow fever that demolished Napoleon’s forces in Haiti during the early nineteenth century [5], and the influenza that caused a pandemic with the highest fatality (around 50 million deaths) in 1918 [6,7]. In the twentieth century, by increasing public health knowledge and interventions, the burden of infectious diseases was reduced, particularly in more developed countries [8]. Furthermore, the later industrialization and urbanization brought great improvements in sanitation, house structural development (such as windows screened with netting), and vector control. These measures collectively ameliorated the transmission rates by reducing contact with particular infectious agents [8,9]. In addition, the discovery of penicillin in 1928, as well as the development of various vaccines, ushered the era of treatment and prevention in public health, significantly contributing to the eradication of certain infectious diseases [10].
After World War II, several health organizations were established, including the US Centers for Disease Control (CDC) and the World Health Organization (WHO) that led multiple campaigns to completely eradicate specific infectious diseases, such as smallpox, a highly infectious viral disease that was completely eradicated by 1980 via vaccination campaigns [11]. These campaigns and actions established optimism and confidence to combat and control various infectious diseases worldwide.
These infectious diseases mentioned above have been identified as emerging infectious diseases (EIDs) and re-emerging infectious diseases (REIDs) [12]. EIDs are diseases that have not occurred in humans before; have occurred previously but affected only small numbers of people in isolated places; or have occurred throughout human history but have only recently been recognized as distinct diseases or as a result of a new mutant strains [12]. According to US CDC, the EIDs are defined as diseases whose incidence numbers in humans have increased in the past two decades, causing public health problems either locally or internationally [13]. REIDs are defined as diseases that were once major health problems and then declined dramatically but are recently reoccurring, leading to major health complications [13]. Although most control and prevention efforts have been implemented, both EIDs and REIDs are still onset intermittently and pose threats and burdens to human health. Some recent human EIDs and REIDs are shown in Table 1.
Table 1.
Examples of recent human emerging or re-emerging infectious disease.
| Infectious Disease | Pathogen | Emerging/Reemerging | Primary Transmission |
|---|---|---|---|
| Virus | |||
| West Nile fever | West Nile virus | Reemerging | Vector-borne |
| Hantavirus pulmonary syndrome | Hantavirus | Emerging | Zoonotic |
| Dengue fever | Dengue virus | Reemerging | Vector-borne |
| Zika virus disease | Zika virus | Reemerging | Vector-borne |
| Yellow fever | Yellow fever virus | Reemerging | Vector-borne |
| Japanese encephalitis | Japanese encephalitis virus | Reemerging | Vector-borne |
| Marburg hemorrhagic fever | Marburg virus | Reemerging | Zoonotic |
| Rift Valley fever | Rift Valley fever virus | Reemerging | Vector-borne |
| Ebola hemorrhagic fever | Ebola virus | Reemerging | Zoonotic |
| Lassa fever | Lassa virus | Reemerging | Zoonotic |
| Hendra virus infection | Hendra virus | Emerging | Zoonotic |
| Nipah virus infection | Nipah virus | Emerging | Zoonotic |
| Highly pathogenic avian influenza | H5N1, H7N9 influenza virus | Emerging | Zoonotic |
| Severe acute respiratory syndrome | SARS-CoV-1 | Emerging | Respiratory (person-to-person) |
| Middle East Respiratory Syndrome | MERS-CoV | Emerging | Zoonotic |
| COVID-19 | SARS-CoV-2 | Emerging | Respiratory (person-to-person) |
| 2009 Pandemic influenza | Swine-origin H1N1 influenza virus | Emerging | Respiratory (person-to-person) |
| Bacteria | |||
| Lyme disease | Borrelia spp. | Emerging | Vector-borne |
| Cholera | Vibrio cholerae | Reemerging | Waterborne |
| Plague | Yersinia pestis | Reemerging | Vector-borne |
| Bartonellosis | Bartonella spp. | Emerging | Zoonotic |
| Vancomycin-resistant Staphylococcus aureus infections | Staphylococcus aureus | Reemerging | Person-to-person |
| Pathogenic Escherichia coli infections | Pathogenic E. coli strains (O157:H7 & O104:H4) |
Emerging | Foodborne |
| Diphtheria | Corynebacterium diphtheriae | Reemerging | Respiratory (person-to-person) |
| Typhoid fever | Salmonella typhi | Reemerging | Foodborne, waterborne |
| Multidrug-resistant tuberculosis infections | Mycobacterium tuberculosis | Reemerging | Respiratory (person-to-person) |
| Fungal | |||
| Cryptococcus gattii infections | Cryptococcus gattii | Emerging | Environmental exposure |
| Parasite | |||
| Cyclosporiasis infections | Cyclospora cayetanensis | Emerging | Foodborne, waterborne |
| Drug-resistant malaria | Plasmodium spp. | Reemerging | Vector-borne |
| Protein | |||
| Variant Creutzfeldt–Jakob disease | Prion | Emerging | Zoonotic, foodborne |
The occurrence of EIDs and REIDs are influenced by a variety of factors, including human behavior, microbial adaptation, ecology, globalization, and public health infrastructure [14]. In addition, most of these factors could be associated with the increasing number of human populations, overcrowding in cities with poor sanitation, fast and intense international traveling, changes in the handling or processing of food, and increased exposure of humans to microbial carrying vectors and reservoirs in nature [15]. In the fourteenth century, the first protective legislation was implemented which evolved over the centuries into the current International Health Regulations [16,17]. The first recorded quarantine regulations were reported in Venice in 1377, which was imposed to protect against diseases carried by ship borne rats [18,19]. Almost five centuries later, the first International Sanitary Conference was held which laid down certain principles for protection against disease, until 1951 when the International Sanitary Regulations was established, providing a framework on quarantine measures [20].
Furthermore, as one of the major factors, travel has always been a channel to the spreading of disease across the world. Therefore, when there are incidences of EIDs or REIDs, most countries will tighten their borders, restricting immigration and initiating strict surveillance on the products confiscated at airports and ports from travelers. For example, COVID-19, an EID, has disseminated from the first reported city (Wuhan, China) to many countries worldwide via global traveling and immigration [21,22,23]. In addition, the African swine fever (ASF), a highly contagious hemorrhagic viral disease associated with high fatality rates in domestic and wild pigs, recently caused outbreaks near the borders of China and has a remarkable capacity for transboundary and transcontinental spread potential, subsequently posing a threat to neighboring countries of China [24,25,26].
Unfortunately, certain pathogens or microorganisms related to EIDs or REIDs are being used as bioweapons to cause the threat of bioterrorism via release of such viruses, bacteria, or other agents leading to additional complexities in how EIDs or REIDs affect global health [27,28]. A number of recent bioterrorism events have had a dramatic impact on public health policies and resource allocations. Some bioterrorism agents used to cause attacks include anthrax, smallpox, melioidosis, and glanders [27]. Although advanced research and technology have provided better diagnostic capabilities as well as basic general knowledge to dissect the various factors and determinants regarding pathogenesis, virulence, cytotoxicity, and micro-host interaction, much of them still remain unknown or not yet fully understood, mandating the necessity of more efforts to address these pathogenic factors and finetune mechanisms [29].
Regarding the transmission route, several EIDs have resulted from animal-to-human transmission. The transmission of a pathogen between animals and humans is known as zoonotic transmission or zoonosis [30]. Zoonosis is currently recognized as one of the most vital pathways for the emergence of new infectious disease to humans. Reports indicated that an estimated 75% of all known EIDs originate from some type of animal reservoir [31,32]. Some examples of zoonotic disease include HIV/AIDS, SARS, MERS, several hemorrhagic fevers, Lyme disease, plague, and avian or swine origin influenza [32,33,34,35,36,37]. Each of these diseases possesses a unique etiology and a direct or indirect transmission route. Humans have a high chance to become infected due to their close contact with asymptomatic or sick animals carrying the new pathogen. Additionally, effective control of zoonotic diseases is particularly difficult, since recognizing an emerging zoonotic disease often does not occur until a major outbreak is already ongoing [31]. If the responsible zoonotic pathogen is highly transmissible, then future epidemic spread will occur even after recognition. As previously mentioned, population growth has had a drastic impact on human health. Greater zoonotic disease potential can result from this growth primarily due to an increased interaction between humans and animal habitats [38].
Several reports indicate that ecology or etiology of EIDs or REIDs are very complex, requiring a sophisticated, interdisciplinary response to reduce disease impact. One strategy to address these complexities has been coined ‘One Health’ [39,40]. One Health is an approach for designing and implementing programs, policies, legislation, and research in which multiple sectors communicate and work together to achieve better public health outcomes. One Health is also a moniker for the interdisciplinary strategy, bringing together human, animal, and environmental health professionals to address complex global health problems [41]. Overall, One Health is an important approach to improve the effectiveness of public health response and interventions as well as recruitment and application of multiple areas of expertise to work together to fight against EIDs or REIDs.
Acknowledgments
The authors wish to thank the staff from Center for Tropical Medicine and Infectious Disease and Kaohsiung Medical University.
Author Contributions
W.-H.W. and A.N.U. analyzed the data and drafted the manuscript. A.T. and S.-F.W. discussed the concept and designed the manuscript. S.-F.W. made critical revisions and gave suggestions of the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
This work was supported by grants from the Ministry of Science and Technology, R.O.C. (MOST 108-2320-B-037-035-MY3, MOST 109-2823-8-037-002-CV & MOST 110-2918-I-037-002) and Kaohsiung Medical University Research Center Grant (KMU-TC109B02).
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Cunha B.A. Historical aspects of infectious diseases, part I. Infect. Dis. Clin. N. Am. 2004;18:11–15. doi: 10.1016/S0891-5520(03)00098-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mukherjee S. Emerging infectious diseases: Epidemiological perspective. Indian J. Dermatol. 2017;62:459–467. doi: 10.4103/ijd.IJD_379_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.McFee R.B. Emerging infectious diseases overview. Dis. Mon. 2018;64:163–169. doi: 10.1016/j.disamonth.2018.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zietz B.P., Dunkelberg H. The history of the plague and the research on the causative agent Yersinia pestis. Int. J. Hyg. Environ. Health. 2004;207:165–178. doi: 10.1078/1438-4639-00259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Patterson K. Yellow fever epidemics and mortality in the United States, 1693–1905. Soc. Sci. Med. 1992;34:855–865. doi: 10.1016/0277-9536(92)90255-O. [DOI] [PubMed] [Google Scholar]
- 6.Yen H.-L., Webster R.G. Pandemic influenza as a current threat. Curr. Top. Microbiol. Immunol. 2009;333:3–24. doi: 10.1007/978-3-540-92165-3_1. [DOI] [PubMed] [Google Scholar]
- 7.Zumla A., Hui D.S. Emerging and reemerging infectious diseases: Global overview. Infect. Dis. Clin. N. Am. 2019;33 doi: 10.1016/j.idc.2019.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Armstrong G.L., Conn L.A., Pinner R.W. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281:61–66. doi: 10.1001/jama.281.1.61. [DOI] [PubMed] [Google Scholar]
- 9.Neiderud C.-J. How urbanization affects the epidemiology of emerging infectious diseases. Infect. Ecol. Epidemiol. 2015;5:27060. doi: 10.3402/iee.v5.27060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Clardy J., Fischbach M., Currie C.R. The natural history of antibiotics. Curr. Biol. 2009;19:R437–R441. doi: 10.1016/j.cub.2009.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Melamed S., Israely T., Paran N. Challenges and achievements in prevention and treatment of smallpox. Vaccines. 2018;6:8. doi: 10.3390/vaccines6010008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tabish S.A. Recent trends in emerging infectious diseases. Int. J. Health Sci. 2009;3:5–8. [PMC free article] [PubMed] [Google Scholar]
- 13.US. CDC Emerging Infectious Diseases. [(accessed on 27 June 2021)];2018 Available online: https://www.cdc.gov/niosh/topics/emerginfectdiseases/default.html.
- 14.Smolinski M.S., Hamburg M.A., Lederberg J., editors. Microbial Threats to Health: Emergence, Detection, and Response. National Academic Press; Washington, DC, USA: 2003. Microbial Threats to Health: Emergence, Detection, and Response. [PubMed] [Google Scholar]
- 15.Lindahl J.F., Grace D. The consequences of human actions on risks for infectious diseases: A review. Infect. Ecol. Epidemiol. 2015;5:30048. doi: 10.3402/iee.v5.30048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bansal R.D., Bhasin S.K. New, emerging and re-emerging infectious diseases. Indian J. Public Health. 1997;41:35. [PubMed] [Google Scholar]
- 17.Longbottom H. Emerging infectious diseases. Commun. Dis. Intell. 1997;21:89–93. doi: 10.33321/cdi.1997.21.19. [DOI] [PubMed] [Google Scholar]
- 18.Ziskind B., Halioua B. The history of quarantine. Rev Prat. 2008;58:2314–2317. [PubMed] [Google Scholar]
- 19.Felkai P. History of quarantine II. Orv. Hetil. 2021;162:474–478. doi: 10.1556/650.2021.HO2676. [DOI] [PubMed] [Google Scholar]
- 20.Howard-Jones N. The scientific background of the International Sanitary Conferences, 1851–1938. 2. WHO Chron. 1974;28:229–247. [PubMed] [Google Scholar]
- 21.Lin C.Y., Wang W.H., Urbina A.N., Tseng S.P., Lu P.L., Chen Y.H., Yu M.L., Wang S.F. Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan. Int. J. Infect. Dis. 2020;97:240–244. doi: 10.1016/j.ijid.2020.06.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Huang S.W., Wang S.F. SARS-CoV-2 entry related viral and host genetic variations: Implications on COVID-19 severity, immune escape, and infectivity. Int. J. Mol. Sci. 2021;22:3060. doi: 10.3390/ijms22063060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Huang S.W., Miller S.O., Yen C.H., Wang S.F. Impact of genetic variability in ACE2 expression on the evolutionary dynamics of SARS-CoV-2 spike D614G mutation. Genes. 2020;12:16. doi: 10.3390/genes12010016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang W.-H., Lin C.-Y., Ishcol M.R.C., Urbina A.N., Assavalapsakul W., Thitithanyanont A., Lu P.-L., Chen Y.-H., Wang S.-F. Detection of African swine fever virus in pork products brought to Taiwan by travellers. Emerg. Microbes Infect. 2019;8:1000–1002. doi: 10.1080/22221751.2019.1636615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sánchez-Cordón P.J., Montoya M., Reis A.L., Dixon L.K. African swine fever: A re-emerging viral disease threatening the global pig industry. Vet. J. 2018;233:41–48. doi: 10.1016/j.tvjl.2017.12.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wang S.-F., Wang W.-H., Ishcol M.R.C., Lin C.-Y. African swine fever: An emerging threat to Asian countries. J. Exp. Clin. Microbiol. 2019;2:14–15. [Google Scholar]
- 27.Grafstein E., Innes G. Bioterrorism: An emerging threat. CJEM. 1999;1:205–209. doi: 10.1017/S148180350000422X. [DOI] [PubMed] [Google Scholar]
- 28.Hamburg A.M. Bioterrorism: Responding to an emerging threat. Trends Biotechnol. 2002;20:296–298. doi: 10.1016/S0167-7799(02)01989-3. [DOI] [PubMed] [Google Scholar]
- 29.Upadhyay M.K., Maroof K.A. Understanding the emerging and reemerging terminologies amid the COVID-19 pandemic. J. Fam. Med. Prim. Care. 2020;9:5881–5887. doi: 10.4103/jfmpc.jfmpc_960_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Richt J.A., Feldmann H. Emerging zoonoses: Recent advances and future challenges. Zoonoses Public Health. 2009;56:257. doi: 10.1111/j.1863-2378.2009.01288.x. [DOI] [PubMed] [Google Scholar]
- 31.WHO Zoonotic Disease: Emerging Public Health Threats in the Region 2021. [(accessed on 27 June 2021)]; Available online: http://www.emro.who.int/about-who/rc61/zoonotic-diseases.html.
- 32.Recht J., Schuenemann V.J., Sánchez-Villagra M.R. Host diversity and origin of zoonoses: The ancient and the new. Animals. 2020;10:1672. doi: 10.3390/ani10091672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kongsomros S., Manopwisedjaroen S., Chaopreecha J., Wang S.-F., Borwornpinyo S., Thitithanyanont A. Rapid and efficient cell-to-cell transmission of avian influenza H5N1 virus in MDCK cells is achieved by trogocytosis. Pathogens. 2021;10:483. doi: 10.3390/pathogens10040483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Yang Z.-S., Huang S.-W., Wang W.-H., Lin C.-Y., Wang C.-F., Urbina A.N., Thitithanyanont A., Tseng S.-P., Lu P.-L., Chen Y.-H., et al. Identification of important N-linked glycosylation sites in the hemagglutinin protein and their functional impact on DC-SIGN mediated avian influenza H5N1 infection. Int. J. Mol. Sci. 2021;22:743. doi: 10.3390/ijms22020743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Huang S.-W., Wang S.-F. The effects of genetic variation on H7N9 avian influenza virus pathogenicity. Viruses. 2020;12:1220. doi: 10.3390/v12111220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wang W.-H., Erazo E.M., Ishcol M.R.C., Lin C.-Y., Assavalapsakul W., Thitithanyanont A., Wang S.-F. Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: A systemic literature review. J. Int. Med. Res. 2019;48:300060519845488. doi: 10.1177/0300060519845488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wang S.-F., Tseng S.-P., Loh E.-W., Wang W.-H., Li M.-C., Chen K.-H., Tsai W.-C., Lee Y.-M., Chen H.-Y., Liu F.-T., et al. Generation and characterization of new monoclonal antibodies against swine origin 2009 influenza A (H1N1) virus and evaluation of their prophylactic and therapeutic efficacy in a mouse model. Dev. Comp. Immunol. 2017;67:8–17. doi: 10.1016/j.dci.2016.10.010. [DOI] [PubMed] [Google Scholar]
- 38.Wu T., Perrings C., Kinzig A., Collins J.P., Minteer B.A., Daszak P. Economic growth, urbanization, globalization, and the risks of emerging infectious diseases in China: A review. Ambio. 2017;46:18–29. doi: 10.1007/s13280-016-0809-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Bhatia R. Implementation framework for one health approach. Indian J. Med. Res. 2019;149:329–331. doi: 10.4103/ijmr.IJMR_1517_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.MacKenzie J.S., Jeggo M. The One health approach—Why is it so important? Trop. Med. Infect. Dis. 2019;4:88. doi: 10.3390/tropicalmed4020088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ahmed N., Ahmed S., Sami A.S. Adverse health events after natural disasters and the ‘One Health’ approach: Animals as vectors for human disease. Infect. Dis. Health. 2019;24:177–178. doi: 10.1016/j.idh.2018.12.005. [DOI] [PubMed] [Google Scholar]
